XML 22 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Change in Stockholders' Equity - USD ($)
Series B Convertible Preferred Stock [Member]
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Beginning balance at Dec. 31, 2020 $ 1 $ 260 $ 16,720,525 $ (17,698,936) $ (171,586) $ (1,149,736)
Beginning balance, shares at Dec. 31, 2020 872,766 2,590,120        
Foreign currency translation gain 266 266
Unrealized gain on marketable securities (77,029) (77,029)
Stock compensation - stock options 1,518,756 1,518,756
Exercise of options $ 9 542,491 542,500
Exercise of options, shares   92,500        
Exercise of warrants $ 27 327,098 327,125
Exercise of warrants, shares   269,170        
Issuance of shares and warrants from offering, net of offering costs $ 80 11,707,959 11,708,039
Issuance of shares and warrants from offering, net of offering costs, shares   795,000        
Conversion of preferred stock $ (1) $ 22 (21)
Conversion of preferred stock,Shares (872,766) 218,192        
Conversion of notes and interest $ 32 1,594,936 1,594,968
Conversion of notes and interest, shares   317,546        
Stock issued for underwriter $ 2 (2)
Stock issued for underwriter, shares   19,875        
Net loss (4,522,934) (4,522,934)
Ending balance at Dec. 31, 2021 $ 432 32,411,742 (22,221,870) (248,349) 9,941,955
Ending balance, shares at Dec. 31, 2021 4,302,403        
Foreign currency translation gain (6,820) (6,820)
Unrealized gain on marketable securities (421,738) (421,738)
Stock compensation - stock options 844,248 844,248
Conversion of notes and interest $ 2 94,893 $ 94,985
Conversion of notes and interest, shares   18,912       18,911
Net loss (3,555,505) $ (3,555,505)
Stock compensation - warrants 20,433 20,433
Ending balance at Dec. 31, 2022 $ 434 $ 33,371,406 $ (25,777,375) $ (676,907) $ 6,917,558
Ending balance, shares at Dec. 31, 2022 4,321,315